The purpose of this study was to evaluate the frequency of promoter gene polymorphisms, to elucidate promoter gene polymorphisms on IL-13 cytokine levels, to determine susceptibility or protection against schistosomiasis and to determine association to risk of prostate cancer development. This evidence concerns the gene IL13 and prostate cancer.